Dr. Jeffrey K. Giguere
Claim this profilePrisma Health Cancer Institute - Faris
Studies Cancer
Studies Breast Cancer
26 reported clinical trials
64 drugs studied
Area of expertise
1Cancer
Stage I
Stage II
PD-L1 positive
2Breast Cancer
Stage IV
HER2 negative
Stage I
Affiliated Hospitals
Clinical Trials Jeffrey K. Giguere is currently running
Digital Tomosynthesis vs. Standard Mammography
for Breast Cancer Screening
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.
Recruiting2 awards Phase 34 criteria
Pembrolizumab + TKI
for Chronic Myeloid Leukemia
This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and persistent detection of minimal residual disease, defined as the levels of a gene product called bcr-abl in the blood. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and dasatinib, imatinib mesylate, or nilotinib may work better in treating patients with chronic myeloid leukemia.
Recruiting1 award Phase 2
More about Jeffrey K. Giguere
Clinical Trial Related7 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Jeffrey K. Giguere has experience with
- Docetaxel
- Questionnaire Administration
- Surgery
- Active Monitoring
- Low Intensity Stepped Care
- High Intensity Stepped Care
Breakdown of trials Jeffrey K. Giguere has run
Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey K. Giguere specialize in?
Jeffrey K. Giguere focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage II.
Is Jeffrey K. Giguere currently recruiting for clinical trials?
Yes, Jeffrey K. Giguere is currently recruiting for 12 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey K. Giguere has studied deeply?
Yes, Jeffrey K. Giguere has studied treatments such as Docetaxel, Questionnaire Administration, Surgery.
What is the best way to schedule an appointment with Jeffrey K. Giguere?
Apply for one of the trials that Jeffrey K. Giguere is conducting.
What is the office address of Jeffrey K. Giguere?
The office of Jeffrey K. Giguere is located at: Prisma Health Cancer Institute - Faris, Greenville, South Carolina 29605 United States. This is the address for their practice at the Prisma Health Cancer Institute - Faris.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.